GSK in £162m deal for Maximuscle maker

MAXIMUSCLE-PROMAX

Lucozade maker GlaxoSmithKline is set to beef up its sports nutrition portfolio with the acquisition of Maximuscle owner Maxinutrition.

 

Already have an account? Sign in here

You’ve used up your article allowance

Sign up to read more stories for free

Register now